NL188642C - 3-aminoalkyl-1h-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking. - Google Patents

3-aminoalkyl-1h-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking.

Info

Publication number
NL188642C
NL188642C NLAANVRAGE8502171,A NL8502171A NL188642C NL 188642 C NL188642 C NL 188642C NL 8502171 A NL8502171 A NL 8502171A NL 188642 C NL188642 C NL 188642C
Authority
NL
Netherlands
Prior art keywords
indool
aminoalkyl
neck
pharmaceutical preparation
sulfonamide compound
Prior art date
Application number
NLAANVRAGE8502171,A
Other languages
English (en)
Dutch (nl)
Other versions
NL8502171A (nl
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10564759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL188642(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8502171A publication Critical patent/NL8502171A/nl
Application granted granted Critical
Publication of NL188642C publication Critical patent/NL188642C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NLAANVRAGE8502171,A 1984-08-01 1985-08-01 3-aminoalkyl-1h-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking. NL188642C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848419575A GB8419575D0 (en) 1984-08-01 1984-08-01 Chemical compounds
GB8419575 1984-08-01

Publications (2)

Publication Number Publication Date
NL8502171A NL8502171A (nl) 1986-03-03
NL188642C true NL188642C (nl) 1992-08-17

Family

ID=10564759

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE8502171,A NL188642C (nl) 1984-08-01 1985-08-01 3-aminoalkyl-1h-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking.
NL930065C NL930065I2 (nl) 1984-08-01 1993-06-11 3-Aminoalkyl-1H-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL930065C NL930065I2 (nl) 1984-08-01 1993-06-11 3-Aminoalkyl-1H-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking.

Country Status (42)

Country Link
US (1) US5037845A (pt)
JP (1) JPH0623197B2 (pt)
KR (1) KR930003759B1 (pt)
AT (1) AT386196B (pt)
AU (1) AU573878B2 (pt)
BE (1) BE903006A (pt)
CA (1) CA1241004A (pt)
CH (1) CH666026A5 (pt)
CZ (1) CZ280530B6 (pt)
DE (1) DE3527648A1 (pt)
DK (1) DK158942C (pt)
DO (1) DOP1989004759A (pt)
EC (1) ECSP941096A (pt)
EG (1) EG17283A (pt)
ES (6) ES8700234A1 (pt)
FI (1) FI78466C (pt)
FR (1) FR2568571B1 (pt)
GB (1) GB8419575D0 (pt)
GR (1) GR851850B (pt)
HK (1) HK33289A (pt)
HU (1) HU201738B (pt)
IE (1) IE58122B1 (pt)
IL (1) IL75986A (pt)
IS (1) IS1430B6 (pt)
IT (1) IT1207325B (pt)
JO (1) JO1379B1 (pt)
KE (1) KE3858A (pt)
LU (2) LU86032A1 (pt)
MA (1) MA20499A1 (pt)
MX (2) MX159672A (pt)
NL (2) NL188642C (pt)
NO (2) NO164653C (pt)
NZ (1) NZ212948A (pt)
PH (2) PH22850A (pt)
PL (1) PL146005B1 (pt)
PT (1) PT80900B (pt)
SE (1) SE452460B (pt)
SK (1) SK404191A3 (pt)
SU (1) SU1498386A3 (pt)
UA (1) UA6329A1 (pt)
ZA (1) ZA855818B (pt)
ZW (1) ZW12485A1 (pt)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270333A (en) * 1986-01-28 1993-12-14 Glaxo Group Limited Indole derivatives
US5155218A (en) * 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
US5935925A (en) * 1990-05-08 1999-08-10 Synaptic Pharmaceutical Corporation Methods of treating migraine and compounds useful for such methods
GB9013845D0 (en) * 1990-06-21 1990-08-15 Glaxo Group Ltd Process
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9101592D0 (en) * 1991-01-24 1991-03-06 Glaxo Group Ltd Compositions
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
AT399870B (de) * 1991-06-06 1995-08-25 Vita Invest Sa Verfahren zur herstellung von 3-(2-(dimethylamino)ethyl)-n-methyl-1h-indol-5- ethansulfonamid
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
ES2059236B1 (es) * 1992-06-18 1995-06-16 Imidex S A Procedimiento para la sintesis de la 3-(2-dimetilamino) etil)-n-metil-1h-indol-5-metanosulfonamida.
ES2055651B1 (es) * 1992-07-20 1995-03-01 Vita Invest Sa Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
AT399871B (de) * 1993-02-15 1995-08-25 Vita Invest Sa Verfahren zur herstellung von 2-carboxy-3-(2- (dimethylamino)ethyl)-n-methyl-1h-indol-5- methansulfonamid und dessen niederalkylestern
US5807571A (en) * 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
ES2084560B1 (es) * 1994-03-09 1997-01-16 Almirall Lab Procedimiento de preparacion de derivados el indol.
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
CA2195107A1 (en) * 1994-08-02 1996-02-15 Richard Alexander Jelley Azetidine, pyrrolidine and piperidine derivatives
US5521197A (en) 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
AU4074897A (en) * 1996-09-18 1998-04-14 Eli Lilly And Company A method for the prevention of migraine
CA2268164A1 (en) * 1996-10-08 1998-04-16 Yao-Chang Xu New serotonin 5-ht1f agonists
GB9714383D0 (en) * 1997-07-08 1997-09-10 Pfizer Ltd Improved process
US6416472B1 (en) 1997-11-06 2002-07-09 Edus Inc. Method and device for measuring cognitive efficiency
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
NZ528377A (en) * 2001-03-27 2005-05-27 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
US20030013753A1 (en) * 2001-06-05 2003-01-16 Ronald Aung-Din Transdermal migraine therapy
US8329734B2 (en) * 2009-07-27 2012-12-11 Afgin Pharma Llc Topical therapy for migraine
FR2827287B1 (fr) * 2001-07-13 2003-10-31 Servier Lab Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
US20060106227A1 (en) * 2002-06-13 2006-05-18 Dr Reddy's Laboratories Limited 3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
CN1176649C (zh) * 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
EP2666772B1 (en) * 2002-12-20 2017-03-01 Basf Se Synthesis of amines and intermediates for the synthesis thereof
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
EP1626956A1 (en) * 2003-05-12 2006-02-22 Potluri, Ramesh Babu A novel process for preparation of indole derivatives
US20070184109A1 (en) * 2003-06-06 2007-08-09 Floyd Alison G Compositions comprising triptans and nsaids
US20070065463A1 (en) * 2003-06-20 2007-03-22 Ronald Aung-Din Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
US20060002989A1 (en) * 2004-06-10 2006-01-05 Ahmed Salah U Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
KR20130136010A (ko) 2005-04-13 2013-12-11 네우렉슨 인코포레이티드 Ｎｏｓ 저해 활성을 갖는 치환된 인돌 화합물
US20070166336A1 (en) * 2005-12-13 2007-07-19 David Delmarre Stable and palatable oral liquid sumatriptan compositions
EP2010527B1 (en) * 2006-04-13 2013-08-14 Neuraxon Inc. 1,5 and 3,6- substituted indole compounds having nos inhibitory activity
AU2007310949A1 (en) * 2006-10-19 2008-04-24 Auspex Pharmaceuticals, Inc. Substituted indoles
US20090076121A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched sumatriptan
US20090163451A1 (en) * 2007-11-16 2009-06-25 Frank Porreca Methods for treating visceral pain
WO2009062319A1 (en) * 2007-11-16 2009-05-22 Neuraxon, Inc. Indole compounds and methods for treating visceral pain
MX2010005343A (es) * 2007-11-16 2010-08-09 Neuraxon Inc Compuestos indola 3, 5-sustituidos que tienen actividad inhibidora de la re-absorcion y el reciclo de nos y norepinefrina.
WO2009128089A2 (en) * 2008-02-11 2009-10-22 Matrix Laboratories Limited Novel solvate form of sumatriptan succinate and process for preparing sumatriptan salt employing the same
US20090252791A1 (en) * 2008-04-02 2009-10-08 Venkata Nookaraju Sreedharala Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
KR101517415B1 (ko) * 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
JP2011526889A (ja) * 2008-06-30 2011-10-20 アフギン ファーマ，エルエルシー 局所局部的神経作用療法
WO2010046399A1 (en) * 2008-10-22 2010-04-29 Novartis Ag Combinations for the treatment of migraine
CA2775404C (en) 2009-09-25 2017-01-03 Dr. Reddy's Laboratories Limited Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
JP5660817B2 (ja) * 2010-07-21 2015-01-28 高田製薬株式会社 スマトリプタンコハク酸塩を含有する内用液剤
CN102432520B (zh) * 2011-11-21 2013-10-09 山东新华制药股份有限公司 3-[2-（二甲氨基）乙基]-n-甲基吲哚-5-甲烷磺酰胺琥珀酸盐的制备方法
BR112017018944A2 (pt) 2015-03-02 2018-05-15 Afgin Pharma Llc método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s)
US10383816B2 (en) 2015-03-02 2019-08-20 Afgin Pharma, Llc Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en) 2016-08-16 2018-02-22 Afgin Pharma, Llc Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE311728C (pt) *
US3322787A (en) * 1964-09-25 1967-05-30 Merck & Co Inc Alpha-hydrazino-beta-(3-indolyl) alkanoic acid derivatives
IT1036004B (it) * 1968-05-21 1979-10-30 Abc Ist Biolog Chem Spa Acidt 3 indolil adetoidrossamici
US4283410A (en) * 1978-06-15 1981-08-11 Miles Laboratories, Inc. 3-Amino or amido-2-(1H-indol-3-yl) propanoic acid derivatives
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
GB2083463B (en) * 1980-08-12 1984-05-10 Glaxo Group Ltd Heterocyclic compounds
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
NZ197996A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 1-(3-(omega-aminoalkyl)-1h-indol-5-yl)alkanamides
GR79215B (pt) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8332434D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Production of chemical compounds

Also Published As

Publication number Publication date
PH22850A (en) 1989-01-19
ATA226685A (de) 1987-12-15
CA1241004A (en) 1988-08-23
SU1498386A3 (ru) 1989-07-30
DE3527648C2 (pt) 1993-08-26
ES8801788A1 (es) 1988-02-16
GB8419575D0 (en) 1984-09-05
FR2568571B1 (fr) 1988-09-23
ES8700234A1 (es) 1986-10-16
NZ212948A (en) 1989-05-29
ES8801900A1 (es) 1988-03-01
MX159672A (es) 1989-08-02
CH666026A5 (fr) 1988-06-30
CZ280530B6 (cs) 1996-02-14
SK277952B6 (en) 1995-09-13
SE452460B (sv) 1987-11-30
ECSP941096A (es) 1995-01-16
ES557483A0 (es) 1988-02-16
NO853046L (no) 1986-02-03
JO1379B1 (en) 1986-11-30
ZW12485A1 (en) 1986-02-26
ZA855818B (en) 1986-04-30
FI78466C (fi) 1989-08-10
SK404191A3 (en) 1995-09-13
PL254800A1 (en) 1986-10-21
KR930003759B1 (ko) 1993-05-10
ES557481A0 (es) 1988-02-16
LU86032A1 (fr) 1986-02-18
JPS6147464A (ja) 1986-03-07
PT80900B (pt) 1987-12-30
AU4568985A (en) 1986-02-06
DE3527648A1 (de) 1986-02-13
HUT40077A (en) 1986-11-28
DK158942B (da) 1990-08-06
DK351185D0 (da) 1985-08-01
ES557482A0 (es) 1988-03-01
AT386196B (de) 1988-07-11
IE58122B1 (en) 1993-07-14
ES545810A0 (es) 1986-10-16
HK33289A (en) 1989-04-28
MX14221A (es) 1993-10-01
PT80900A (en) 1985-09-01
EG17283A (en) 1992-06-30
NL930065I1 (nl) 1993-09-01
IS3034A7 (is) 1986-02-02
PL146005B1 (en) 1988-12-31
CZ404191A3 (en) 1993-04-14
IE851918L (en) 1986-02-01
AU573878B2 (en) 1988-06-23
NO164653C (no) 1990-11-07
ES557480A0 (es) 1988-02-16
SE8503680D0 (sv) 1985-08-01
JPH0623197B2 (ja) 1994-03-30
HU201738B (en) 1990-12-28
IS1430B6 (is) 1990-07-16
US5037845A (en) 1991-08-06
ES8801789A1 (es) 1988-02-16
NL8502171A (nl) 1986-03-03
IT8548435A0 (it) 1985-08-01
FI852969A0 (fi) 1985-08-01
FR2568571A1 (fr) 1986-02-07
PH24117A (en) 1990-03-05
DOP1989004759A (es) 1999-02-06
LU88266I2 (pt) 1994-02-03
KR860001788A (ko) 1986-03-22
FI78466B (fi) 1989-04-28
ES8801790A1 (es) 1988-02-16
IL75986A (en) 1989-02-28
NL930065I2 (nl) 1993-10-01
DK158942C (da) 1991-01-21
ES8801204A1 (es) 1987-12-16
MA20499A1 (fr) 1986-04-01
NO164653B (no) 1990-07-23
KE3858A (en) 1989-06-02
ES552047A0 (es) 1987-12-16
IT1207325B (it) 1989-05-17
GR851850B (pt) 1985-11-26
IL75986A0 (en) 1985-12-31
BE903006A (fr) 1986-02-03
DK351185A (da) 1986-02-02
NO1994023I1 (no) 1994-11-09
SE8503680L (sv) 1986-02-02
UA6329A1 (uk) 1994-12-29
FI852969L (fi) 1986-02-02

Similar Documents

Publication Publication Date Title
NL188642C (nl) 3-aminoalkyl-1h-indool-5-methaansulfonamideverbinding en farmaceutisch preparaat met halsslagader-vernauwende werking.
NL194578B (nl) Farmaceutisch preparaat met cyclosporine.
NL195028B (nl) Cyclosporinebevattend farmaceutisch preparaat.
FI853913A0 (fi) Farmaceutiska foereningar som antracyklinglykosider.
DE3580304D1 (de) Arzneimittel.
IT1212778B (it) Composizioni farmaceutiche adattivita&#39; antiinfiammatoria e/o analgesica, non ulcerogene.
IT8422142A0 (it) Procedimento di preparazione. cefem composti ad azione farmaceutica e relativo
FI893643A0 (fi) Farmaceutiska kompositioner.
FI872733A0 (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
FI872313A0 (fi) Farmaceutiska kompositioner.
DE3576118D1 (de) Pharmazeutische praeparate.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1213453B (it) Composizione farmaceutica.
DE3682960D1 (de) Pharmazeutische praeparate.
IT8521498A0 (it) Isoindolinil-alchil-piperazine adattivita&#39; farmaceutica.
NO874193D0 (no) Farmasoeytiske preparater.
FI852658L (fi) Farmaceutiska aemnen.
IT1216783B (it) 8 alfa acilamminoergoline ,loro preparazione e loro impiego come medicamenti
FI875616A (fi) Farmaceutiska blandningar.
NO864967D0 (no) Leddkonstruksjon.
IT8619594A0 (it) Acid 8-osso-2-ossa-1-azabiciclo 4.2.0 ottano-3-carbossilici.
FI840076A (fi) Den flygande apparaten.
IT8520591A0 (it) Formulazione farmaceutica.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
KC1 Grant of a supplementary protection certificate

Free format text: PRODUCT NAME: SUMATRIPTANUM OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT DAARVAN (WAARONDER HYDRAAT), IN HET BIJZONDER SUMATRIPTANI SUC CINAS.

Spc suppl protection certif: 930065

Filing date: 19930611

Extension date: 20060515

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20050801